The soluble magnesium stent has various advantages, including lower long-term risks associated with permanent stents and improved blood channel repair.
This novel treatment demonstrates Al Qassimi Hospital's dedication to implementing cutting-edge medical technologies and offering state-of-the-art patient care. The hospital continues to be a leader in providing sophisticated medical treatments and improving health outcomes in the region.
Dr Arif Al Nooryani, Director of Al Qassimi Hospital in Sharjah, confirmed that this achievement constitutes a revolution in the field of soluble stents. According to him, the Middle East is implanting these stents for the first time, using specific specifications from the business Biotronik, which received European CE Marking approval in February 2024.
Dr Al Nooryani explained that Al Qassimi Hospital is always striving to adopt cutting-edge technology, including the most recent stents from around the world, with the goal of making significant advances in medicine that combine efficacy and safety, thereby opening up new horizons for innovative and safe cardiac treatment. He applauded Emirates Health Services' efforts to assist its health facilities with cutting-edge medical technology.
He stated that this type of stent is an excellent treatment for cardiac disorders such as coronary stenosis because it expands the arteries and improves blood flow to the heart, lowering the risk of serious complications and helping patients regain their quality of life. He explained that current soluble cardiac stents are more effective over time, in addition to their role in lowering healthcare expenditures and improving cardiac disease treatment outcomes.
These stents dissolve within 6 months to a year, leaving no trace. They also preserve the flexibility of the coronary arteries, the strength of blood flow through them, and the ability to use this artery in the future if the patient has open heart surgery.
For an optimal experience, please
